TPL2 Activation and Prostate Cancer Growth
Author Information
Author(s): Jeong Joseph H., Bhatia Ayesha, Toth Zsolt, Oh Soohwan, Inn Kyung-Soo, Liao Chun-Peng, Roy-Burman Pradip, Melamed Jonathan, Coetzee Gerhard A., Jung Jae U.
Primary Institution: USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
Hypothesis
Is TPL2 a key driver of androgen depletion-independent prostate cancer growth?
Conclusion
TPL2 kinase plays a critical role in promoting androgen depletion-independent prostate cancer progression.
Supporting Evidence
- TPL2 is upregulated in androgen depletion-independent prostate cancers.
- Suppressing TPL2 reduces prostate cancer cell growth under low androgen conditions.
- High frequency of TPL2 overexpression in human ADI prostate cancer samples suggests its potential as a treatment target.
Takeaway
This study found that a protein called TPL2 helps prostate cancer grow even when testosterone is low, which is important for finding new treatments.
Methodology
The study screened a library of activated human kinases to identify TPL2's role in prostate cancer growth.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website